AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 124 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $66,000 | +112.9% | 4,342 | +5.7% | 0.00% | 0.0% |
| Q2 2022 | $31,000 | +520.0% | 4,109 | +721.8% | 0.00% | – |
| Q1 2022 | $5,000 | -94.3% | 500 | -95.9% | 0.00% | -100.0% |
| Q4 2021 | $87,000 | +148.6% | 12,330 | +297.7% | 0.00% | +100.0% |
| Q3 2021 | $35,000 | -52.7% | 3,100 | -32.8% | 0.00% | -50.0% |
| Q2 2021 | $74,000 | -29.5% | 4,615 | -21.7% | 0.00% | 0.0% |
| Q1 2021 | $105,000 | +303.8% | 5,895 | +213.7% | 0.00% | +100.0% |
| Q4 2020 | $26,000 | -44.7% | 1,879 | -52.6% | 0.00% | 0.0% |
| Q3 2020 | $47,000 | -32.9% | 3,968 | -16.3% | 0.00% | -66.7% |
| Q2 2020 | $70,000 | +7.7% | 4,742 | +76.1% | 0.00% | -40.0% |
| Q4 2019 | $65,000 | +109.7% | 2,693 | +66.0% | 0.01% | +150.0% |
| Q3 2019 | $31,000 | -27.9% | 1,622 | +11.2% | 0.00% | -33.3% |
| Q2 2019 | $43,000 | +1333.3% | 1,458 | +2330.0% | 0.00% | – |
| Q1 2019 | $3,000 | -85.7% | 60 | -82.3% | 0.00% | -100.0% |
| Q3 2018 | $21,000 | -22.2% | 339 | -32.6% | 0.00% | 0.0% |
| Q1 2018 | $27,000 | +575.0% | 503 | +618.6% | 0.00% | +100.0% |
| Q4 2017 | $4,000 | -98.2% | 70 | -98.5% | 0.00% | -94.7% |
| Q3 2017 | $226,000 | +1783.3% | 4,651 | +1862.4% | 0.02% | +1800.0% |
| Q2 2017 | $12,000 | 0.0% | 237 | -75.1% | 0.00% | -50.0% |
| Q1 2016 | $12,000 | -80.3% | 951 | -72.5% | 0.00% | -66.7% |
| Q3 2015 | $61,000 | +258.8% | 3,461 | +249.6% | 0.01% | +200.0% |
| Q2 2015 | $17,000 | +466.7% | 990 | +953.2% | 0.00% | – |
| Q1 2015 | $3,000 | -91.2% | 94 | -92.0% | 0.00% | -100.0% |
| Q4 2014 | $34,000 | -34.6% | 1,173 | -43.6% | 0.00% | -57.1% |
| Q2 2014 | $52,000 | +108.0% | 2,080 | +47.6% | 0.01% | +75.0% |
| Q4 2013 | $25,000 | – | 1,409 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |